The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.
Beta-blockers show no benefit for heart attack patients with normal heart function
- Post author:
- Post published:April 8, 2024
- Post category:uncategorized